NCT06880614

Brief Summary

The goal of this trial is to test the effect of house cricket (Acheta domesticus) preload on glycemic response in diabetic patients. The main question\[s\] it aims to answer are: whether house cricket powder could lower blood glucose spike and stimulate higher insulin response. Participants will consume either house cricket powder, whey protein isolate or placebo which will be mixed with a chicken-flavored soup. Participants fingers will be pricked for up to 2 hours. Researcher will compare house cricket powder with placebo to see if the glycemic response is better in house cricket supplemented group. Researcher will compare house cricket powder with whey protein isolate to see if both supplement induce comparable glycemic response.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 17, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

March 14, 2025

Last Update Submit

December 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood glucose

    Blood glucose concentration measured using glucometer. Participants fingers are pricked and using capillary tube, a drop of the blood is dripped in a test strip before inserted to a glucometer.

    120 minutes

Secondary Outcomes (1)

  • Blood insulin

    120 minutes

Study Arms (3)

Placebo

PLACEBO COMPARATOR

This arm will be given chicken-flavored soup without any supplements before conducting the oral glucose tolerance test

Diagnostic Test: Oral Glucose Tolerance test (75g 2-hour)Dietary Supplement: Placebo

Whey

ACTIVE COMPARATOR

This arm will be given chicken-flavored soup containing whey isolate powder before conducting the oral glucose tolerance test

Diagnostic Test: Oral Glucose Tolerance test (75g 2-hour)Dietary Supplement: Whey

House Cricket

EXPERIMENTAL

This arm will be given chicken-flavored soup containing house cricket powder before conducting the oral glucose tolerance test

Diagnostic Test: Oral Glucose Tolerance test (75g 2-hour)Dietary Supplement: House cricket

Interventions

The participants are required to drink a glucose solution containing 75 g of glucose dissolved in 250 mL of water

House CricketPlaceboWhey
WheyDIETARY_SUPPLEMENT

Supplemented with whey protein isolate masked with a chicken-flavored soup

Whey
House cricketDIETARY_SUPPLEMENT

Supplemented with house cricket powder masked with chicken-flavored soup

House Cricket
PlaceboDIETARY_SUPPLEMENT

Placebo consists of chicken-flavored soup without any supplement inside

Placebo

Eligibility Criteria

Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Suffering from type 2 diabetes mellitus (HbA1c \> 6.5%)
  • Consume metformin for at least 6 months

You may not qualify if:

  • Consume other type of anti-diabetic drugs
  • Presenting any food allergy
  • Recent surgery or infections that may affect oral glucose tolerance test
  • Consume other drugs that may affect oral glucose tolerance test
  • Not consuming any anti-diabetic drugs
  • Pre-diabetes (HbA1c 5.7 - 6.4%)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth Hospital Kota Kinabalu

Kota Kinabalu, Sabah, 88200, Malaysia

Location

Related Publications (5)

  • Clifton PM, Galbraith C, Coles L. Effect of a low dose whey/guar preload on glycemic control in people with type 2 diabetes--a randomised controlled trial. Nutr J. 2014 Oct 25;13:103. doi: 10.1186/1475-2891-13-103.

    PMID: 25343850BACKGROUND
  • Oberoi A, Giezenaar C, Rigda RS, Horowitz M, Jones KL, Chapman I, Soenen S. Effects of co-ingesting glucose and whey protein on blood glucose, plasma insulin and glucagon concentrations, and gastric emptying, in older men with and without type 2 diabetes. Diabetes Obes Metab. 2023 May;25(5):1321-1330. doi: 10.1111/dom.14983. Epub 2023 Feb 22.

    PMID: 36694303BACKGROUND
  • Jakubowicz D, Froy O, Ahren B, Boaz M, Landau Z, Bar-Dayan Y, Ganz T, Barnea M, Wainstein J. Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia. 2014 Sep;57(9):1807-11. doi: 10.1007/s00125-014-3305-x. Epub 2014 Jul 10.

    PMID: 25005331BACKGROUND
  • Dai J, Lov J, Martin-Arrowsmith PW, Gritsas A, Churchward-Venne TA. The acute effects of insect vs. beef-derived protein on postprandial plasma aminoacidemia, appetite hormones, appetite sensations, and energy intake in healthy young men. Eur J Clin Nutr. 2022 Nov;76(11):1548-1556. doi: 10.1038/s41430-022-01157-8. Epub 2022 May 10.

    PMID: 35538144BACKGROUND
  • Kashima H, Uemoto S, Eguchi K, Endo MY, Miura A, Kobayashi T, Fukuba Y. Effect of soy protein isolate preload on postprandial glycemic control in healthy humans. Nutrition. 2016 Sep;32(9):965-9. doi: 10.1016/j.nut.2016.02.014. Epub 2016 Mar 8.

    PMID: 27157469BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Glucose Tolerance TestWhey

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineInvestigative TechniquesMilkBeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and Beverages

Study Officials

  • Ashril Yusof, PhD

    University of Malaya

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Randomized, Cross over, Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 14, 2025

First Posted

March 17, 2025

Study Start

June 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

December 9, 2025

Record last verified: 2025-12

Locations